Marker Therapeutics, Inc. (MRKR)
1.475
+0.06
(+3.87%)
USD |
NASDAQ |
Jun 08, 16:00
1.475
0.00 (0.00%)
After-Hours: 16:36
Marker Therapeutics Total Liabilities (Quarterly) : 3.638M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 120.24M |
| Vericel Corp. | 129.40M |
| ADMA Biologics, Inc. | 274.86M |
| Gyre Therapeutics, Inc. | 24.19M |
| Savara, Inc. | 45.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.43M |
| Shareholders Equity (Quarterly) | 13.80M |
| Current Ratio | 4.792 |